See also this year's filing and all EDGAR filings for this company.
PDF Report 0001274792_2020_Merrimack_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001274792, Merrimack Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 18,692,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 1,390,000 |
| 4 | LiabilitiesCurrent | 2,770,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 16,236,416 |
| 9 | ResearchAndDevelopmentExpense | 2,715,149 |
| 10 | remainder_Expenses | -6,740,643 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 8,212,449 |
| 13 | remainder_ComprehensiveNetIncome | 4,987 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 20,082,000 |
| 1 | Liabilities | 2,770,000 |
| 2 | Expenses | 12,210,922 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 17,312,000 |
| 5 | NetIncome | -3,998,473 |
| 6 | ComprehensiveNetIncome | -3,995,980 |
| 7 | BaseVar | 21,640,179 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.95 |
| 9 | EconomicCapitalRatio | 3.66 |
Edgar->Model Mapping
Feature Distribution
Change over Time
